Lanean...

Clinical potential of brodalumab in the management of psoriasis: the evidence to date

Brodalumab is an anti-IL-17 receptor monoclonal antibody currently in development for the treatment of moderate-to-severe plaque psoriasis. With many systemic psoriasis therapies to choose from, and several newer agents in development, physicians need up to date evidence for the use of these drugs....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Psoriasis (Auckl)
Egile Nagusiak: Sandoval, Laura F, Williams, Brooke, Feldman, Steven R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2015
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5683110/
https://ncbi.nlm.nih.gov/pubmed/29387580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PTT.S49996
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!